http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0109255-A3

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-1745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-1782
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D319-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C247-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-1785
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C247-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C241-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C239-00
filingDate 1983-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1985-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0109255-A3
titleOfInvention Glycerol derivatives
abstract Glycerol derivatives of the general formula: n n[wherein A represents an oxygen atom or a carbonyloxy group n(i.e. -O-CO-, in which the carbonyl group should be attached to na group R³ and the oxa group should be attached to the carbon natom at the third position of the glycerol skeleton), R¹ repre­nsents an alkyl group of 6 to 22 carbom atoms, or an alkyl group nof 2 to 5 carbon atoms being substituted by a phenyl group, R² nrepresents an azido group (-N₃ group), an amino group (-NH₂ ngroup) or a group of the general formula: -NHCOR⁵, - nNHCOOR⁵ or -NHCONHR⁵, in which R⁵ represents an alkyl ngroup of 1 to 10 carbon atoms or a phenyl group, with the pro­nviso that, when A represents a carbonyloxy group, R² does not nrepresent an amino group, R³ represents an alkylene group of n1 to 12 carbon atoms and R⁴ represents an amino group, or a ngroup of the general formula: -NHCOR⁶, -NHR⁷, -N(R⁷)₂ or n-(R⁷)₃ · , in which R⁶ represents an alkyl group of 1 to 6 ncarbon atoms or a phenyl group, R⁷ represents an alkyl group nof 1 to 8 carbon atoms, with the proviso that, when R⁴ repre­nsents a group of the formula: -N(R⁷)₂ or -(R⁷)₃ · n, two or nmore of R⁷ may be same or different to each other, and n rep­nresents an anion of an acid], and non-toxic acid addition salts nthereof, possess antagonistic effect on PAF, hypotensive ef­nfect like PAF, inhibitory effect on phospholiphase and inhibito­nry effect on growth of tumour cell or induction of differentia­ntion, and are, therefore, useful as a platelet aggregation inhibi­ntor, anti-asthmatic agent, anti-allergic agent, anti-inflamma­ntory agent, hypotensive agent and anti-tumour agent for mam­nmals.
priorityDate 1982-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2835369-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455502157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688

Total number of triples: 55.